-
1
-
-
0037022910
-
Inflammation and atherosclerosis
-
11877368 10.1161/hc0902.104353 1:CAS:528:DC%2BD38XislWhu7k%3D
-
Libby, P., P.M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105: 1135-1143.
-
(2002)
Circulation
, vol.105
, pp. 1135-1143
-
-
Libby, P.1
Ridker, P.M.2
Maseri, A.3
-
2
-
-
0036181394
-
Inflammation in acute coronary syndromes
-
11847151 10.1136/heart.87.3.201 1:STN:280:DC%2BD387hsVGjsA%3D%3D
-
Mulvihill, N.T., and J.B. Foley. 2002. Inflammation in acute coronary syndromes. Heart 87: 201-204.
-
(2002)
Heart
, vol.87
, pp. 201-204
-
-
Mulvihill, N.T.1
Foley, J.B.2
-
3
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
15843671 10.1056/NEJMra043430 1:CAS:528:DC%2BD2MXjsFCltrc%3D
-
Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
4
-
-
38749112555
-
Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction
-
18160725 10.1373/clinchem.2007.097360 1:CAS:528:DC%2BD1cXmtFelsg%3D%3D
-
Packard, R.R., and P. Libby. 2008. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38.
-
(2008)
Clin Chem
, vol.54
, pp. 24-38
-
-
Packard, R.R.1
Libby, P.2
-
5
-
-
52949085287
-
Chemokines in atherosclerosis: An update
-
18566299 10.1161/ATVBAHA.107.161174 1:CAS:528:DC%2BD1cXht1Ggtb%2FL
-
Zernecke, A., E. Shagdarsuren, and C. Weber. 2008. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 28: 1897-1908.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1897-1908
-
-
Zernecke, A.1
Shagdarsuren, E.2
Weber, C.3
-
6
-
-
8544275811
-
Interleukin-18: Recent advances
-
15548995 10.1097/01.moh.0000141926.95319.42 1:CAS:528:DC%2BD2cXhtVyktrjI
-
Reddy, P. 2004. Interleukin-18: recent advances. Curr Opin Hematol 11: 405-410.
-
(2004)
Curr Opin Hematol
, vol.11
, pp. 405-410
-
-
Reddy, P.1
-
7
-
-
0031705349
-
Production of functional IL-18 by different subtypes of murine and human dendritic cells(DC): DC-derived IL-18 enhances IL-12-dependent Th1 development
-
9808192 10.1002/(SICI)1521-4141(199810)28:10<3231: AID-IMMU3231>3.0.CO;2-Q 1:CAS:528:DyaK1cXmvFektbY%3D
-
Stoll, S., H. Jonuleit, E. Schmitt, et al. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells(DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 28: 3231-3239.
-
(1998)
Eur J Immunol
, vol.28
, pp. 3231-3239
-
-
Stoll, S.1
Jonuleit, H.2
Schmitt, E.3
-
8
-
-
0033781944
-
Dendritic cells and their involvement in atherosclerosis
-
11048894 10.1097/00041433-200010000-00009 1:CAS:528:DC%2BD3cXnt12js7s%3D
-
Bobryshev, Y.V. 2000. Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 11: 511-517.
-
(2000)
Curr Opin Lipidol
, vol.11
, pp. 511-517
-
-
Bobryshev, Y.V.1
-
9
-
-
0037148510
-
Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages; Implications for atherogenesis
-
11805151 10.1084/jem.20011022 1:CAS:528:DC%2BD38XosFCntw%3D%3D
-
Gerdes, N., G.K. Sukhova, P. Libby, et al. 2002. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages; implications for atherogenesis. J Exp Med 195: 245-257.
-
(2002)
J Exp Med
, vol.195
, pp. 245-257
-
-
Gerdes, N.1
Sukhova, G.K.2
Libby, P.3
-
10
-
-
33747091335
-
Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury
-
16864728 10.1161/CIRCULATIONAHA.105.602714 1:CAS:528:DC%2BD28Xnt1agsbc%3D
-
Maffia, P., G. Grassia, P. Di Meglio, et al. 2006. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation 114: 430-437.
-
(2006)
Circulation
, vol.114
, pp. 430-437
-
-
Maffia, P.1
Grassia, G.2
Di Meglio, P.3
-
11
-
-
2442618177
-
Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death
-
14960579 10.1074/jbc.M313980200 1:CAS:528:DC%2BD2cXjs1Whtbo%3D
-
Chandrasekar, B., K. Vemula, R.M. Surabhi, et al. 2004. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18- mediated human cardiac endothelial cell death. J Biol Chem 279: 20221-20233.
-
(2004)
J Biol Chem
, vol.279
, pp. 20221-20233
-
-
Chandrasekar, B.1
Vemula, K.2
Surabhi, R.M.3
-
12
-
-
28844441556
-
Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation
-
16325763 10.1016/j.bbrc.2005.11.100 1:CAS:528:DC%2BD2MXhtlajtLbJ
-
Chandrasekar, B., A.J. Valente, G.L. Freeman, et al. 2006. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation. Biochem Biophys Res Commun 339: 956-963.
-
(2006)
Biochem Biophys Res Commun
, vol.339
, pp. 956-963
-
-
Chandrasekar, B.1
Valente, A.J.2
Freeman, G.L.3
-
13
-
-
33744963247
-
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin
-
16554298 10.1074/jbc.M600200200 1:CAS:528:DC%2BD28XltVequr4%3D
-
Chandrasekar, B., S. Mummidi, L. Mahimainathan, et al. 2006. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem 281: 15099-15109.
-
(2006)
J Biol Chem
, vol.281
, pp. 15099-15109
-
-
Chandrasekar, B.1
Mummidi, S.2
Mahimainathan, L.3
-
14
-
-
0037040211
-
Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma
-
11834721 10.1161/hh0202.105292 1:CAS:528:DC%2BD38Xhtl2ltbw%3D
-
Whitman, S.C., P. Ravisankar, and A. Daugherty. 2002. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 90: E34-E38.
-
(2002)
Circ Res
, vol.90
-
-
Whitman, S.C.1
Ravisankar, P.2
Daugherty, A.3
-
15
-
-
10644233212
-
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice
-
15472128 10.1161/01.ATV.0000147126.99529.0a
-
de Nooijer, R., J. von der Thusen, C.J. Verkleij, et al. 2004. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 24: 2313-2319.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 2313-2319
-
-
De Nooijer, R.1
Von Der Thusen, J.2
Verkleij, C.J.3
-
16
-
-
23244463732
-
Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease
-
16043644 10.1161/CIRCULATIONAHA.104.519702 1:CAS:528:DC%2BD2MXmsV2jt7Y%3D
-
Tiret, L., T. Godefroy, E. Lubos, et al. 2005. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112(5): 643-650.
-
(2005)
Circulation
, vol.112
, Issue.5
, pp. 643-650
-
-
Tiret, L.1
Godefroy, T.2
Lubos, E.3
-
17
-
-
0035205687
-
Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation
-
11108943 10.1016/S0165-5728(00)00407-0 1:CAS:528:DC%2BD3cXosFeqsbc%3D
-
Giedraitis, V., B. He, W.X. Huang, et al. 2001. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112(1-2): 146-152.
-
(2001)
J Neuroimmunol
, vol.112
, Issue.1-2
, pp. 146-152
-
-
Giedraitis, V.1
He, B.2
Huang, W.X.3
-
18
-
-
65249126723
-
Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease
-
18599493
-
Liu, W., Q. Tang, H. Jiang, et al. 2009. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease. Angiology 60(2): 180-185.
-
(2009)
Angiology
, vol.60
, Issue.2
, pp. 180-185
-
-
Liu, W.1
Tang, Q.2
Jiang, H.3
-
19
-
-
14644414825
-
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
-
15522916
-
Grutz, G. 2005. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 77: 3-15.
-
(2005)
J Leukoc Biol
, vol.77
, pp. 3-15
-
-
Grutz, G.1
-
20
-
-
33745804042
-
Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy
-
16772342 10.1093/eurheartj/ehl058 1:CAS:528:DC%2BD28Xot1Cgtbo%3D
-
Nishihira, K., T. Imamura, A. Yamashita, et al. 2006. Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J 27: 1685-1689.
-
(2006)
Eur Heart J
, vol.27
, pp. 1685-1689
-
-
Nishihira, K.1
Imamura, T.2
Yamashita, A.3
-
21
-
-
0028063408
-
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
-
7989608 10.1172/JCI117619 1:CAS:528:DyaK2MXisFWgsrg%3D
-
Galis, Z.S., G.K. Sukhova, M.W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
-
(1994)
J Clin Invest
, vol.94
, pp. 2493-2503
-
-
Galis, Z.S.1
Sukhova, G.K.2
Lark, M.W.3
Libby, P.4
-
22
-
-
0037381597
-
Tiret L:Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
-
12668489 10.1161/01.CIR.0000058700.41738.12 1:CAS:528: DC%2BD3sXit12msLo%3D
-
Blankenberg, S., H.J. Rupprecht, O. Poirier, C. Bickel, and F. Cambien. 2003. Tiret L:Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107: 1579-1585.
-
(2003)
Circulation
, vol.107
, pp. 1579-1585
-
-
Blankenberg, S.1
Rupprecht, H.J.2
Poirier, O.3
Bickel, C.4
Cambien, F.5
-
23
-
-
0024284028
-
A simple salting out procedure for extracting DNA from human nucleated cells
-
3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
-
Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3): 1215.
-
(1988)
Nucleic Acids Res
, vol.16
, Issue.3
, pp. 1215
-
-
Miller, S.A.1
Dykes, D.D.2
Polesky, H.F.3
-
24
-
-
38049187753
-
Cubic exact solutions for the estimation of pairwise haplotype frequencies: Implications for linkage disequilibrium analyses and a web tool 'Cubex'
-
10.1186/1471-2105-8-428
-
Gaunt, T.R., S. Rodriguez, and I.N. Day. 2007. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'Cubex'. BMC Bioinform. 8: 428.
-
(2007)
BMC Bioinform.
, vol.8
, pp. 428
-
-
Gaunt, T.R.1
Rodriguez, S.2
Day, I.N.3
-
25
-
-
0033757955
-
Coronary in-stent restenosis-predictors, treatment and prevention
-
11052838 10.1053/euhj.2000.2153 1:STN:280:DC%2BD3M%2Fpslyisw%3D%3D
-
Hoffmann, R., and G.S. Mintz. 2000. Coronary in-stent restenosis-predictors, treatment and prevention. Eur Heart J 21: 1739-1749.
-
(2000)
Eur Heart J
, vol.21
, pp. 1739-1749
-
-
Hoffmann, R.1
Mintz, G.S.2
-
26
-
-
33644763311
-
In stent restenosis: Bane of the stent era
-
16505271 10.1136/jcp.2005.025742 1:CAS:528:DC%2BD28XivVKksbk%3D
-
Mitra, A.K., and D.K. Agrawal. 2006. In stent restenosis: bane of the stent era. J Clin Pathol 59: 232-239.
-
(2006)
J Clin Pathol
, vol.59
, pp. 232-239
-
-
Mitra, A.K.1
Agrawal, D.K.2
-
27
-
-
53849085513
-
ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention
-
18374923 10.1016/j.atherosclerosis.2008.01.011 1:CAS:528: DC%2BD1cXht1Kltr7P
-
Shah, S.H., E.R. Hauser, D. Crosslin, et al. 2008. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis 201(1): 148-154.
-
(2008)
Atherosclerosis
, vol.201
, Issue.1
, pp. 148-154
-
-
Shah, S.H.1
Hauser, E.R.2
Crosslin, D.3
-
28
-
-
38449099940
-
Identification of a polymorphism of UCP3 associated with recurrent in-stent restenosis of coronary arteries
-
17786284 1:CAS:528:DC%2BD2sXht1Srt7jM
-
Oguri, M., K. Kato, T. Hibinot, et al. 2007. Identification of a polymorphism of UCP3 associated with recurrent in-stent restenosis of coronary arteries. Int J Mol Med 20: 533-538.
-
(2007)
Int J Mol Med
, vol.20
, pp. 533-538
-
-
Oguri, M.1
Kato, K.2
Hibinot, T.3
-
29
-
-
40849133988
-
The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients
-
18361937 10.1016/j.humimm.2007.12.003 1:CAS:528:DC%2BD1cXjs1Sqtr0%3D
-
Miranda-Malpica, E., M.A. Martinez-Rios, J.M. Fragoso, et al. 2008. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients. Hum Immunol 69: 116-121.
-
(2008)
Hum Immunol
, vol.69
, pp. 116-121
-
-
Miranda-Malpica, E.1
Martinez-Rios, M.A.2
Fragoso, J.M.3
-
30
-
-
0033491194
-
Interleukin-18: A novel cytokine that augments both innate and acquired immunity
-
9755340 10.1016/S0065-2776(08)60389-2 1:CAS:528:DyaK1MXmsVOh
-
Okamura, H., H. Tsutsui, S. Kashiwamura, et al. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70: 281-312.
-
(1998)
Adv Immunol
, vol.70
, pp. 281-312
-
-
Okamura, H.1
Tsutsui, H.2
Kashiwamura, S.3
-
31
-
-
0142055947
-
New markers of inflammation and endothelial cell activation: PartI
-
14568885 10.1161/01.CIR.0000089190.95415.9F
-
Szmitko, P.E., C.H. Wang, R.D. Weisel, et al. 2003. New markers of inflammation and endothelial cell activation: partI. Circulation 108: 1917-1923.
-
(2003)
Circulation
, vol.108
, pp. 1917-1923
-
-
Szmitko, P.E.1
Wang, C.H.2
Weisel, R.D.3
-
32
-
-
0035797867
-
Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability
-
11581135 10.1161/hc3901.096721 1:CAS:528:DC%2BD3MXotVehtrc%3D
-
Mallat, Z., A. Corbaz, A. Scoazec, et al. 2001. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104: 1598-1603.
-
(2001)
Circulation
, vol.104
, pp. 1598-1603
-
-
Mallat, Z.1
Corbaz, A.2
Scoazec, A.3
-
33
-
-
33744963247
-
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin
-
10.1074/jbc.M600200200 1:CAS:528:DC%2BD28XltVequr4%3D
-
Chandrasekar, B., S. Mummidi, L. Mahimainathan, et al. 2006. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. Biol Chem 281: 15099-15109.
-
(2006)
Biol Chem
, vol.281
, pp. 15099-15109
-
-
Chandrasekar, B.1
Mummidi, S.2
Mahimainathan, L.3
-
34
-
-
27744450819
-
Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study
-
16243298 10.1016/j.bbrc.2005.10.012 1:CAS:528:DC%2BD2MXht1WjurbK
-
Liang, X.H., W. Cheung, C.K. Heng, et al. 2005. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 338: 736-741.
-
(2005)
Biochem Biophys Res Commun
, vol.338
, pp. 736-741
-
-
Liang, X.H.1
Cheung, W.2
Heng, C.K.3
-
35
-
-
0034001964
-
Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits
-
10.1161/01.CIR.101.8.908
-
Laurent, J., L.J. Feldman, L. Aguirre, et al. 2000. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 101: 908-916.
-
(2000)
Circulation
, vol.101
, pp. 908-916
-
-
Laurent, J.1
Feldman, L.J.2
Aguirre, L.3
|